Events

Field Safety Notices about Capture-R® Ready-ID®

According to Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), this field safety notices involved a device in Slovenia that was produced by Immucor.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
    2017-02-20
  • Event Country
    Slovenia
  • Event Source
    AMPMDRS
  • Notes / Alerts
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • Extra notes in the data
  • Reason
    Immucor is issuing this product notification regarding the v antigen typing for donor d1741, cell #4 on capture-r ready-id, lots id324 and id325. further dna testing of donor d1741 has confirmed the donor as v–, instead of v+ as indicated on the master list. .

Device

Capture-R® Ready-ID®
  • Model / Serial
    UDI: 0066204: 10888234001140 0066214: 10888234001188
  • Manufacturer
    Immucor

Manufacturer

Immucor
  • Manufacturer Parent Company (2017)
    Grifols Sa
  • Source
    AMPMDRS